2nd Health Innovation Conference

How do we Assess Innovation in Healthcare?

Healthcare systems have an urgent need for innovative solutions across the range of healthcare services: patient supply, technology and management and management tools. Solutions that will meet a key goal: “Achieve more and better results by giving the less or same amount of money”.

The purpose of the 2nd Health Innovation Conference, which will be held on May 17, 2018 in Athens, is to highlight such innovative solutions.

The conference starts in

00
Days
00
Hours
00
Minutes
00
Seconds

Speakers

Frénoy Edith

Director of Market Access/HTA, European Federation of Pharmaceutical Industries Associations (EFPIA)

Bersimis Sotirios

President, Hellenic Organization for Health Care Services Provision (EOPYY), Assistant Professor, Department of Statistics and Insurance Science, University of Piraeus

Podimatas Yiannis

Special Advisor, Ministry of Health

Antonopoulos Christos

MD PhD, Business Unit Director, BU Oncology/ Hematology, AstraZeneca Greece

Apostolidis Kathi

Vice President, ECPC-European Cancer Patient Coalition & President, Hellenic Cancer Federation (ELLOΚ)

Gazouli Maria

Associate Professor, Medical School, NKUA

Gkikas Spiros

General Manager Greece & Cyprus, GE Healthcare

Gravanis Achilleas

Professor of Pharmacology, School of Medicine University of Crete, Researcher IMBB-FORTH, Affiliated Research Professor, Center of Drug Discovery, Northeastern University 

Iosifidis Philip

Managing Partner Europe, Iota Omega Ventures

Jakoncic Agata

Managing Director, MSD Greece, Cyprus & Malta

Kalamitsis George

Chair of Board, Hellenic Liver Patients Association "Prometheus", President, Committee Protecting the Rights of Recipients of Health Services

Kletsas George

Manager, Technology, Greece & Balkans, IQVIA

Kouvelas Dimitrios

MD, BPharm, PhD, Professor, Clinical Pharmacology & Head of the Clinical Pharmacology Department, School of Medicine, Aristotle University of Thessaloniki

Kyriacou Kyriacos

Ph.D, FRMS Senior Biochemist, Head of the Department of EM/Molecular Pathology, Dean, The Cyprus School of Molecular Medicine The Cyprus Institute of Neurology and Genetics

Liatsikos Evangelos

MD, PhD, Professor, Department of Urology, University of Patras, Greece , Head of Endourology - Laparoscopy Unit, Chairman of European Section of Urotechnology (ESUT)

Nasioulas George

Chief Scientific Director, GeneKor MSA

Ouzounis Konstantinos

General Manager, Ethos Media S.A.

Papadimitriou Olympios

President, SFEE & General Manager, Novo Nordisk Hellas

Papataxiarchis Makis

Managing Director, Janssen Greece, Pharmaceutical Companies of Johnson & Johnson

Rentoumis Anastasios

Health Services Manager, Innovation Manager & President, NGO "Alliance for Integrated Care"

Sakellaridis Fotis

CEO, Qualia Pharma

Stafylas Panos

MD, MSc, PhD Cardiologist/ HTA & eHealth Consultant, Managing Director of HealThink LP, Thessaloniki

Tsiafos – Tsiaras Sotiris

Military Pharmacist, MSc Logistics & Supply Chain Management, OR Traceability project manager, 401 Athens General Army Hospital

Vardas Panos

MD, PhD (London, UK), Chairman of Heart Sector, Hygeia Hospitals Group, Past President of the European Society of Cardiology, Visiting Professor, Imperial College, UK, Chief Strategy Officer of ESC/ European Heart Agency, Brussels

Vlontzos Yiannis

President and Managing Director Greece & Cyprus Merck Hellas SA, Vice – President, Responsible for HTA and Negotiation, Hellenic Association of Pharmaceutical Companies (SFEE)

Vratimos Thanasis

Co-founder & Business Developer, GIVMED

Zoumpoulakis Panagiotis

Ph.D., MBA, Researcher B, Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation

Agenda

Thursday 17 May2018

08.30-09.00

Registration & Coffee

09.00-09.10
photo

Welcome Address

Ouzounis Konstantinos

09.10-09.20
09.20-09.30
photo

Opening Remark

Papataxiarchis Makis

09.30-09.45
09.45-10.05
10.05-10.25
10.25-10.45
photo

Speech

Zoumpoulakis Panagiotis

«Entrepreneurship in biotechnology. The case of M.Sc. “Bioentrepreneurship”»

10.45-11.05
photo

Speech

Iosifidis Philip

«Managing Large Collaborative Programmes with Multiple Stakeholders; Challenges and Outlooks»

11.05-11.45

Roundtable 1: “Synergies between Public and Private Sector for the Promotion of Health Innovation”

• Achilleas Gravanis, Professor of Pharmacology, School of Medicine University of Crete • Researcher IMBB-FORTH, Affiliated Research Professor, Center of Drug Discovery, Northeastern University • Fotis Sakellaridis, CEO, Qualia Pharma • Panagiotis Zoumpoulakis, Ph.D., MBA, Researcher B, Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation • C. Philip Iosifidis, Managing Partner Europe, Iota Omega Ventures • Katia Karalis*, Executive Vice President of Research, Emulate, Inc.

11.45-12.15

Coffee & Networking Break

12.15-12.25
photo

Speech

Kletsas George

«Will Blockchain be the final piece of the puzzle in the technology revolution of Healthcare?»

12.25-12.35
12.35-12.50

12.50-13.05
photo

Speech

Vardas Panos

«Cardiovascular Medicine at a Crossroad: Cutting-edge technologies and Value-Based Medicine»

13.20-13.30
photo

Speech

Gkikas Spiros

«Innovation and Medtech Management»

13.30-14.30

Lunch & Networking Break

14.30-14.50
photo

Speech

Kyriacou Kyriacos

«The contribution of genetics in the diagnosis and treatment of cancer»

14.50-15.10
photo

Speech

Antonopoulos Christos

“The value of personalization: Biomarkers for the clinical management of cancer patients. How health care system can efficiently use its resources?”

15.10-15.25
photo

Speech

Jakoncic Agata

«Health Innovation is a prerequisite for sustainable health care systems»

15.25-16.05

Roundtable 2: “Biomarkers and Cancer genetics”

• Professor Kyriacos Kyriacou, Ph.D, FRMS, Senior Biochemist, Head of the Department of EM/Molecular Pathology, Dean, The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics • Georgios Nasioulas, PhD, Chief Scientific Officer, Genekor MSA • Dr. Sotirios Bersimis, President, Hellenic Organization for Health Care Services Provision (EOPYY), Assistant Professor, Department of Statistics and Insurance Science, University of Piraeus • Maria Gazouli, Associate Professor, Medical School, NKUA • Christos Antonopoulos, MD PhD, Business Unit Director BU Oncology/ Hematology, AstraZeneca Greece

16.05-16.25
photo

Speech

Frénoy Edith

«HTA cooperation in Europe: can it support the Greek debate?»

16.25-16.45

Speech

Kostas Athanassakis, BSc Econ, Msc Econ, PhD, Research Fellow, Department of Health Economics, National School of Public Health (NSPH, Greece)

16.45-17.45

Roundtable 3: “Health Technology Assessment: challenges, hurdles and prospects”

• Yiannis Vlontzos, President and Managing Director Greece & Cyprus Merck Hellas SA & Vice– President, Responsible for HTA and Negotiation, Hellenic Association of Pharmaceutical Companies (SFEE) • Kathi Apostolidis, President, Hellenic Cancer Federation & Vice-Presinent, ECPC-European Cancer Patient Coalition • George Kalamitsis, Chair of Board, Hellenic Liver Patients Association "Prometheus" • Dimitrios Kouvelas, MD, BPharm, PhD, Professor, Clinical Pharmacology & Head of the Clinical Pharmacology Department, School of Medicine, Aristotle University of Thessaloniki • Kostas Athanassakis, BSc Econ, Msc Econ, PhD, Research Fellow, Department of Health Economics, National School of Public Health (NSPH, Greece) • Yiannis Podimatas, Special Advisor, Ministry of Health • Panos Stafylas, MD, MSc, PhD, Cardiologist/ HTA & eHealth Consultant, Managing Director of HealThink LP, Thessaloniki

Sponsors

Venue

Ethniki Asfalistiki Conference Center